Taking people in Hollandia1/2. fázis
A study of the safety and efficacy of MB-dNPM-1-TCR.1 in patients with relapsed or refractory AML.
Key facts
- Where
- Leiden, HollandiaSee the site
- Phase
- 1/2. fázis
Where in Hollandia
- Academisch Ziekenhuis LeidenLeiden, HollandiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Miltenyi Biomedicine GmbH
- Trial code
- EU 2023-505806-41-00
- Record updated
- 2026. március 30.